Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 278 citing articles:

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
Yongjun Wang, Shuya Li, Yuesong Pan, et al.
The Lancet (2023) Vol. 401, Iss. 10377, pp. 645-654
Closed Access | Times Cited: 156
Thrombolysis for acute ischaemic stroke: current status and future perspectives
Georgios Tsivgoulis, Aristeidis H. Katsanos, Else Charlotte Sandset, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 418-429
Closed Access | Times Cited: 155
European Stroke Organisation (ESO) expedited recommendation on tenecteplase for acute ischaemic stroke
Sonia Alamowitch, Guillaume Turc, Lina Palaiodimou, et al.
European Stroke Journal (2023) Vol. 8, Iss. 1, pp. 8-54
Open Access | Times Cited: 89
Stroke
Nina A. Hilkens, Barbara Casolla, Thomas Leung, et al.
The Lancet (2024) Vol. 403, Iss. 10446, pp. 2820-2836
Closed Access | Times Cited: 85
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
Gregory W. Albers, Mouhammad Jumaa, Barbara Purdon, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 8, pp. 701-711
Closed Access | Times Cited: 70
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy
Michael I. D′Angelica, Ryan J. Ellis, Jason B. Liu, et al.
JAMA (2023) Vol. 329, Iss. 18, pp. 1579-1579
Open Access | Times Cited: 64
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke
Steven Warach, Annemarei Ranta, Joosup Kim, et al.
JAMA Neurology (2023) Vol. 80, Iss. 7, pp. 732-732
Open Access | Times Cited: 56
Most Promising Approaches to Improve Stroke Outcomes: The Stroke Treatment Academic Industry Roundtable XII Workshop
Lawrence R. Wechsler, Opeolu Adeoye, Fana Alemseged, et al.
Stroke (2023) Vol. 54, Iss. 12, pp. 3202-3213
Open Access | Times Cited: 44
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
Yunyun Xiong, Bruce Campbell, Lee H. Schwamm, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 3, pp. 203-212
Closed Access | Times Cited: 39
Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke
Johannes Kaesmacher, Fabiano Cavalcante, Manon Kappelhof, et al.
JAMA (2024) Vol. 331, Iss. 9, pp. 764-764
Open Access | Times Cited: 38
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
The Lancet (2024) Vol. 403, Iss. 10444, pp. 2597-2605
Closed Access | Times Cited: 32
Reteplase versus Alteplase for Acute Ischemic Stroke
Shuya Li, Hongqiu Gu, Hao Li, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2264-2273
Closed Access | Times Cited: 32
Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones
Maryam Adenike Salaudeen, Nura Bello, Rabi’u Nuhu Danraka, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 305-305
Open Access | Times Cited: 25
Endovascular Treatment of Medium Vessel Occlusion Stroke
Johanna M. Ospel, Thanh N. Nguyen, Ashutosh P. Jadhav, et al.
Stroke (2024) Vol. 55, Iss. 3, pp. 769-778
Closed Access | Times Cited: 24
A Randomized Controlled Trial of Tenecteplase Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion (TEMPO-2): Rational and design of a multicenter, randomized open-label clinical trial.
Nishita Singh, Carol Kenney, Kenneth Butcher, et al.
International Journal of Stroke (2024) Vol. 19, Iss. 7, pp. 817-822
Closed Access | Times Cited: 24
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial
Mark Parsons, Vignan Yogendrakumar, Leonid Churilov, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 8, pp. 775-786
Closed Access | Times Cited: 22
Tenecteplase Plus Butyphthalide for Stroke Within 4.5–6 Hours of Onset (EXIT-BT): a Phase 2 Study
Dawei Chen, Mingrui Chen, Yu Cui, et al.
Translational Stroke Research (2024)
Closed Access | Times Cited: 20
Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial
Yunyun Xiong, Liyuan Wang, Yuesong Pan, et al.
Stroke and Vascular Neurology (2024), pp. svn-003048
Open Access | Times Cited: 20
Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial
Shuya Li, Runqi Wangqin, Yuesong Pan, et al.
Stroke and Vascular Neurology (2024), pp. svn-002694
Open Access | Times Cited: 19
Intravenous tenecteplase for acute ischemic stroke between 4.5 and 6 h of onset (EXIT-BT2): Rationale and Design
Yihan Wang, Zhen‐Ni Guo, Mingrui Chen, et al.
European Stroke Journal (2024)
Open Access | Times Cited: 19
Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke
Liyuan Wang, Manjun Hao, Na Wu, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 18
Canadian Stroke Best Practice Recommendations: Acute Stroke Management, 7th Edition Practice Guidelines Update, 2022
Manraj K.S. Heran, Patrice Lindsay, Gord Gubitz, et al.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2022) Vol. 51, Iss. 1, pp. 1-31
Open Access | Times Cited: 59
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial
Melinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 2, pp. 117-126
Open Access | Times Cited: 52
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update.
Liping Liu, Zixiao Li, Hongyu Zhou, et al.
PubMed (2023) Vol. 8, Iss. 6, pp. e3-e3
Closed Access | Times Cited: 34
Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
Nan Yang, Hangil Lee, Chuanjie Wu
Brain Circulation (2023) Vol. 9, Iss. 2, pp. 61-63
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top